Click here to go to the previous page
Endocrine Management of the Bariatric Patient
Program Code:
CMF09
Date:
Monday, June 6, 2011
Time:
2:45 PM to 3:05 PM
EST
SPEAKER
(S):
Caroline Margaret Apovian, MD, Boston Med Ctr
Disclosures: CMA: Advisory Group Member, Amylin Pharmaceuticals, Johnson & Johnson, Pfizer, Inc., Abbott Laboratories, Allergan, Orexigen; Principal Investigator, Atkins Foundation, Metaproteomics, Amylin Pharmaceuticals.
Lee Michael Kaplan, MD, PHD, Massachusetts General Hospital
Disclosure: LMK: Consultant, Amylin Pharmaceuticals, Medtronic Minimed, Allergan; Principal Investigator, Johnson & Johnson, Merck & Co.; Scientific Board Member, Rhythm Pharmaceuticals, GI Dynamics, Gelesis.